Delivery Order SPE2DR25D1100-SPE2DR26FCS9X
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,329.60 to AmerisourceBergen Drug Corp for 500 microgram vials of dactinomycin, a chemotherapy medication used in cancer treatment. The contract, which is firm fixed price with no set-aside designation, was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxorubicin 200 mg/100 mL vials totaling $1,928.51 with a firm fixed price arrangement. The contract, which is non-set-aside and competitively awarded, was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,126.05 to AmerisourceBergen Drug Corp for Doxorubicin Liposome 50mg/25ml on July 31, 2025, with completion scheduled for August 1, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical distributor. The order is being fulfilled from the vendor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Doxorubicin Liposome 20mg/10ml in 10ml vials, with a contract ceiling value of $1,922.10 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,523.65 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a small-value pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $19,328.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a $16,208.20 delivery order contract (4570030738) to AmerisourceBergen Drug Corp on November 17, 2025, for pharmaceutical products and related medical supplies. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The place of performance...